Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

American Oncology Network Inc.

Healthcare US AONC

10.0USD
0.00(0%)

Last update at 2026-06-02T13:30:00Z

Day Range

10.0010.00
LowHigh

52 Week Range

0.000414.25
LowHigh

Fundamentals

  • Previous Close 10.00
  • Market Cap336.36M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-5.57500M
  • Revenue TTM1759.48M
  • Revenue Per Share TTM128.27
  • Gross Profit TTM 120.48M
  • Diluted EPS TTM-0.89

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Income before tax -24.46000M -62.50700M 2.59M 0.35M 21.17M
Minority interest 22.98M 57.61M - - -
Net income -3.97300M -5.54200M 2.59M -0.10500M 21.95M
Selling general administrative 133.94M 100.71M 89.89M 77.05M 44.03M
Selling and marketing expenses - - - - -
Gross profit 117.85M 82.80M 95.45M 77.96M 66.11M
Reconciled depreciation 19.37M 16.74M 17.08M 6.08M 3.66M
Ebit -17.55600M -56.09000M 6.01M 1.77M 22.28M
Ebitda 1.81M -39.35100M 23.09M 7.85M 25.94M
Depreciation and amortization 19.37M 16.74M 17.08M 6.08M 3.66M
Non operating income net other - - - - -
Operating income -17.42900M -49.15400M 5.57M 0.91M 22.07M
Other operating expenses 1776.91M 1328.34M 1144.10M 942.84M 702.67M
Interest expense 7.06M 6.42M 3.42M 1.42M 1.12M
Tax provision 2.50M 0.38M 0.00000M 0.46M -0.78300M
Interest income 3.20M 1.33M 0.15M 0.13M 0.03M
Net interest income -3.85800M -5.09100M -3.26600M -1.29200M -1.08400M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.50M 0.38M 1026.64M 0.46M -0.78300M
Total revenue 1759.48M 1279.18M 1149.67M 943.75M 724.74M
Total operating expenses 135.28M 131.95M 89.89M 77.05M 44.03M
Cost of revenue 1641.64M 1196.39M 1054.22M 865.79M 658.64M
Total other income expense net 10.40M -13.35300M 0.29M 0.74M 0.18M
Discontinued operations - - - - -
Net income from continuing ops -26.95800M -63.15000M 2.59M -0.10500M 21.95M
Net income applicable to common shares - - 2.51M -0.10500M 19.43M
Preferred stock and other adjustments - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Total assets 470.33M 374.45M 326.23M 248.30M 0.00957M
Intangible assets 2.48M - - - -
Earning assets - - - - -
Other current assets 8.49M 4.28M 2.67M 3.28M -
Total liab 362.32M 368.73M 264.21M 188.75M 0.01M
Total stockholder equity 18.77M -161.72700M -14.20355M -0.02088M -0.00083M
Deferred long term liab - - - - -
Other current liab 33.15M 33.52M 24.84M 26.43M 0.01M
Common stock 0.00400M 0.00400M 676.24M 0.67M 36.28M
Capital stock 64.99M 0.00400M - - -
Retained earnings -102.17100M -161.81200M 25.83M 23.24M -0.00083M
Other liab - - 4.13M 5.72M 3.03M
Good will 10.90M - - - -
Other assets - - 7.28M 6.26M 7.49M
Cash 62.85M 28.54M 26.93M 27.35M -
Cash and equivalents - - - - -
Total current liabilities 216.85M 169.04M 140.94M 119.34M 0.01M
Current deferred revenue - - - - -
Net debt 84.52M 99.79M 100.20M 36.34M -
Short term debt 12.23M 7.88M 9.60M - -
Short long term debt 3.74M - - - -
Short long term debt total 147.37M 128.32M 127.13M 63.69M -
Other stockholder equity 55.92M -64.98600M -716.15602M -23.92826M -
Property plant equipment - - 75.70M 32.65M 28.66M
Total current assets 331.47M 277.80M 242.02M 208.28M 164.21M
Long term investments 0.00000M - - - -
Net tangible assets - - 60.79M 58.43M 59.15M
Short term investments 9.79M 35.39M 9.85M 0.00000M -
Net receivables 189.63M 165.03M 166.10M 138.12M 97.92M
Long term debt 87.12M 80.64M 80.30M 63.69M -
Inventory 60.71M 44.57M 36.48M 34.53M 22.06M
Accounts payable 170.74M 127.64M 106.50M 92.91M 70.34M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.03M 0.08M -0.11700M - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 26.95M 7.59M 7.28M 6.26M 0.00957M
Deferred long term asset charges - - - - -
Non current assets total 138.86M 96.65M 84.21M 40.02M 0.00957M
Capital lease obligations 56.50M 47.68M 46.83M 0.00000M -
Long term debt total - - - - -
Breakdown 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Type yearly yearly yearly yearly yearly
Date 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Investments -2.41100M -35.53400M -13.99100M -10.69400M -14.67400M
Change to liabilities - - 14.08M 21.68M 34.00M
Total cashflows from investing activities -2.41100M -35.40000M -13.99100M -10.69400M -14.67400M
Net borrowings -4.71000M -0.59300M 15.82M 27.70M -12.06500M
Total cash from financing activities 41.66M 55.13M 15.35M 26.54M 16.26M
Change to operating activities - - -14.21900M -15.39100M 19.88M
Net income -26.95800M -63.15000M 2.59M -0.10500M 21.95M
Change in cash 34.31M 1.61M -5.42800M -10.48800M 38.83M
Begin period cash flow 28.54M 26.93M 32.35M 42.84M 4.01M
End period cash flow 62.85M 28.54M 26.93M 32.35M 42.84M
Total cash from operating activities -4.94300M -18.11800M -6.78400M -26.33800M 37.24M
Issuance of capital stock 50.00M 65.00M 0.00000M 0.00000M 28.50M
Depreciation 19.37M 16.74M 17.08M 6.08M 3.66M
Other cashflows from investing activities -1.06300M 1.25M 1.09M 0.16M -1.52000M
Dividends paid - - - - -
Change to inventory -13.67100M -8.09000M -1.94700M -10.26000M -6.27200M
Change to account receivables -21.51000M 6.95M -24.87300M -30.80300M -35.48500M
Sale purchase of stock -0.36800M -9.56900M - - -
Other cashflows from financing activities -3.25800M 0.30M 15.77M 38.85M 12.34M
Change to netincome - - -0.12100M 2.10M -0.50700M
Capital expenditures 20.95M 12.28M 7.19M 8.32M 12.22M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -20.36800M 12.07M -26.96200M -34.77500M 12.13M
Stock based compensation 16.08M 4.87M -0.69600M 0.02M 0.02M
Other non cash items 4.20M 10.96M -0.06900M 1.66M 0.67M
Free cash flow -25.89700M -30.40100M -13.97700M -34.66000M 25.02M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AONC
American Oncology Network Inc.		 - -% 10.00 - - 0.19 - 0.21 201.87
HCA
HCA Healthcare, Inc.		 -4.12 1.12% 363.23 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 -0.18 1.69% 10.50 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 0.08 1.48% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

American Oncology Network, Inc., through its subsidiaries, provides oncology management services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services, including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.

American Oncology Network Inc.

14543 Global Parkway, Fort Myers, FL, United States, 33913

Key Executives

Name Title Year Born
Mr. Todd Schonherz CEO & Director 1969
Dr. Stephen Divers M.D. Chief Medical Officer, VC of Board of Managers & Chairman of Advisory Board Executive Committee 1973
Mr. David H. Gould CPA Chief Financial Officer 1970
Mr. Mark Moch Chief Information Officer NA
Ms. Kristin Matisziw Chief Compliance & Risk Officer NA
Ms. Erica Mallon General Counsel 1988
Ms. Caroline Hewitt Vice President of Marketing NA
Ms. Bridget Russo Vice President of Human Resources NA
Mr. James Gilmore Pharm.D. Chief Pharmacy & Clinical Services Officer NA
Ms. Shelly Glenn Chief Growth & Relationship Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.